OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their efficiency in expressing complex biologics. Enhancing these processes involves adjusting various variables, including cell line engineering, media composition, and bioreactor settings. A key goal is to maximize antibody yield while minimizing production costs a